Evidence map›Paper›PMID 41855594›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2026

Overlooked aspects of scaling enzyme activity through abundance across tissues and individuals: Insights from k

Zubida M Al-Majdoub, Jill Barber, Amin Rostami-Hodjegan, Aleksandra Galetin, Daniel Scotcher

Abstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zubida M Al-MajdoubCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, United Kingdom. Electronic address: Zubida.al-majdoub@manchester.ac.uk.
Jill BarberCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, United Kingdom.
Amin Rostami-HodjeganCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, United Kingdom; Certara Predictive Technologies, Sheffield, United Kingdom.
Aleksandra GaletinCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, United Kingdom.
Daniel ScotcherCentre for Applied Pharmacokinetic Research, University of Manchester, Manchester, United Kingdom. Electronic address: Daniel.Scotcher@manchester.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediction of human intestinal metabolism within physiologically based pharmacokinetic models is now well established within drug development. Extrapolation of in vitro kinetic parameters accounts for differences in abundance between different in vitro systems and tissues. The existing data assume that the activity of CYP3A4 is consistent between the intestine and liver once adjusted for its tissue-specific expression level. However, the validity of this assumption for other enzymes and other tissues remains uncertain. In the current study, indicators of "activity per unit of enzyme," namely, turnover number (k

Indexed as

Cytochrome P-450 Enzyme SystemGlucuronosyltransferaseIntestinal MucosaLiverMicrosomes, LiverFemaleHumansIntestinesKineticsMaleMicrosomesModels, BiologicalCytochrome P-450 Enzyme SystemGlucuronosyltransferaseCytochrome P450Drug metabolismIntestineLiverPhysiologically based pharmacokinetic modelingUDP-glucuronosyltransferase

Identifiers

PMID41855594
PMCPMC13197946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.